YTHDC2 and breast carcinoma: For example, ZCRB1 was overexpressed in lymphoma, and ADH1C in cervical cancer and esophageal cancer, and YTHDC2 in breast cancer, gastric cancer, head and neck cancer, myeloma, and sarcoma (Figure 5A).